NovaBay Pharmaceuticals, Inc. — Director's Dealing 2011

Jan 6, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovaBay Pharmaceuticals, Inc. (NBY)
CIK: 0001389545
Period of Report: 2011-01-03

Reporting Person: Dailley Anthony (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-03	Option (right to buy)	$1.6700	A	15000.0000	Acquired	2021-01-02	Common Stock (15000.0000)	Direct

Footnotes

F1: Granted pursuant to NovaBay Pharmaceuticals, Inc. Director Compensation Plan.

F2: Stock Option will vest in equal monthly installments over one year starting from the date of the grant.